Polyvinyl pyrrolidone (PVP)-coated AgNPs inhibited both HIV-1 cell-free and cell-associated infection and showed that, as virucidal agents, they prevent the infection regardless of viral tropism or resistance profile, bind to envelope glycoprotein gp120 and therefore prevent CD4-dependent virion binding and infectivity. Here, CD4 is linked to infection.